Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

David Carbone

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Procedures

Gene Therapy

Physiology

Concepts & Ideas

Molecular Sequence Data

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Carbone David P
Profiles in variation: lung carcinogenesis.
Adachi Yasushi; Li Rong; Yamamoto Hiroyuki; Min Yongfen; Piao Wenhua; Wang Yu; Imsumran Arisa; Li Hua; Arimura Yoshiaki; Lee Choon-Taek; Imai Kohzoh; Carbone David P; Shinomura Yasuhisa
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Mutter Robert; Lu Bo; Carbone David P; Csiki Ildiko; Moretti Luigi; Johnson David H; Morrow Jason D; Sandler Alan B; Shyr Yu; Ye Fei; Choy Hak
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of David Carbone (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Carbone David P
Profiles in variation: lung carcinogenesis.
Cancer prevention research (Philadelphia, Pa.) 2009;2(8):695-7.
2009: Adachi Yasushi; Li Rong; Yamamoto Hiroyuki; Min Yongfen; Piao Wenhua; Wang Yu; Imsumran Arisa; Li Hua; Arimura Yoshiaki; Lee Choon-Taek; Imai Kohzoh; Carbone David P; Shinomura Yasuhisa
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Carcinogenesis 2009;30(8):1305-13.
2009: Mutter Robert; Lu Bo; Carbone David P; Csiki Ildiko; Moretti Luigi; Johnson David H; Morrow Jason D; Sandler Alan B; Shyr Yu; Ye Fei; Choy Hak
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2158-65.
2008: Keedy Vicki; Wang Wei; Schiller Joan; Chada Sunil; Slovis Bonnie; Coffee Keith; Worrell John; Thet Lyn A; Johnson David H; Carbone David P
Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4166-71.
2008: Ryzhov Sergey; Novitskiy Sergey V; Zaynagetdinov Rinat; Goldstein Anna E; Carbone David P; Biaggioni Italo; Dikov Mikhail M; Feoktistov Igor
Host A(2B) adenosine receptors promote carcinoma growth.
Neoplasia (New York, N.Y.) 2008;10(9):987-95.
2008: Novitskiy Sergey V; Ryzhov Sergey; Zaynagetdinov Rinat; Goldstein Anna E; Huang Yuhui; Tikhomirov Oleg Y; Blackburn Michael R; Biaggioni Italo; Carbone David P; Feoktistov Igor; Dikov Mikhail M
Adenosine receptors in regulation of dendritic cell differentiation and function.
Blood 2008;112(5):1822-31.
2008: Piao Wenhua; Wang Yu; Adachi Yasushi; Yamamoto Hiroyuki; Li Rong; Imsumran Arisa; Li Hua; Maehata Tadateru; Ii Masanori; Arimura Yoshiaki; Lee Choon-Taek; Shinomura Yasuhisa; Carbone David P; Imai Kohzoh
Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas.
Molecular cancer therapeutics 2008;7(6):1483-93.
2008: Yang Li; Huang Jianhua; Ren Xiubao; Gorska Agnieszka E; Chytil Anna; Aakre Mary; Carbone David P; Matrisian Lynn M; Richmond Ann; Lin P Charles; Moses Harold L
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
Cancer cell 2008;13(1):23-35.
2007: Yildiz Pinar B; Shyr Yu; Rahman Jamshedur S M; Wardwell Noel R; Zimmerman Lisa J; Shakhtour Bashar; Gray William H; Chen Shuo; Li Ming; Roder Heinrich; Liebler Daniel C; Bigbee William L; Siegfried Jill M; Weissfeld Joel L; Gonzalez Adriana L; Ninan Mathew; Johnson David H; Carbone David P; Caprioli Richard M; Massion Pierre P
Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(10):893-901.
2007: Albert Jeffrey M; Gonzalez Adriana; Massion Pierre P; Chen Heidi; Olson Sandra J; Shyr Yu; Diaz Roberto; Lambright Eric S; Sandler Alan; Carbone David P; Putnam Joe B; Johnson David H; Lu Bo
Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(9):1845-51.
2007: Konishi Jun; Kawaguchi Keiko S; Vo Huan; Haruki Nobuhiro; Gonzalez Adriana; Carbone David P; Dang Thao P
Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Cancer research 2007;67(17):8051-7.
2007: Huang Yuhui; Chen Xiaolan; Dikov Mikhail M; Novitskiy Sergey V; Mosse Claudio A; Yang Li; Carbone David P
Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.
Blood 2007;110(2):624-31.
2007: Yang Li; Amann Joseph M; Kikuchi Takefumi; Porta Rut; Guix Marta; Gonzalez Adriana; Park Kyung-Ho; Billheimer Dean; Arteaga Carlos L; Tai Hsin-Hsiung; DuBois Raymond; Carbone David P; Johnson David H
Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.
Cancer research 2007;67(12):5587-93.
2007: Taguchi Fumiko; Solomon Benjamin; Gregorc Vanesa; Roder Heinrich; Gray Robert; Kasahara Kazuo; Nishio Makoto; Brahmer Julie; Spreafico Anna; Ludovini Vienna; Massion Pierre P; Dziadziuszko Rafal; Schiller Joan; Grigorieva Julia; Tsypin Maxim; Hunsucker Stephen W; Caprioli Richard; Duncan Mark W; Hirsch Fred R; Bunn Paul A; Carbone David P
Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.
Journal of the National Cancer Institute 2007;99(11):838-46.
2007: Imsumran Arisa; Adachi Yasushi; Yamamoto Hiroyuki; Li Rong; Wang Yu; Min Yongfen; Piao Wenhua; Nosho Katsuhiko; Arimura Yoshiaki; Shinomura Yasuhisa; Hosokawa Masao; Lee Choon-Taek; Carbone David P; Imai Kohzoh
Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma.
Carcinogenesis 2007;28(5):947-56.
2007: Lee Yoon-Jin; Imsumran Arisa; Park Mi-Young; Kwon Sung-Youn; Yoon Ho Il; Lee Jae-Ho; Yoo Chul-Gyu; Kim Young Whan; Han Sung Koo; Shim Young-Soo; Piao Wenhua; Yamamoto Hiroyuki; Adachi Yasushi; Carbone David P; Lee Choon-Taek
Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway.
Lung cancer (Amsterdam, Netherlands) 2007;55(3):279-86.
2007: Shinohara Eric T; Gonzalez Adriana; Massion Pierre P; Olson Sandra J; Albert Jeffrey M; Shyr Yu; Carbone David P; Johnson David H; Hallahan Dennis E; Lu Bo
PDGFR-beta expression in small cell lung cancer patients.
International journal of radiation oncology, biology, physics 2007;67(2):431-7.
2007: Kikuchi Takefumi; Carbone David P
Proteomics analysis in lung cancer: challenges and opportunities.
Respirology (Carlton, Vic.) 2007;12(1):22-8.
2007: Chung Christine H; Levy Shawn; Chaurand Pierre; Carbone David P
Genomics and proteomics: emerging technologies in clinical cancer research.
Critical reviews in oncology/hematology 2007;61(1):1-25.
2006: Yang Li; Huang Yuhui; Porta Rut; Yanagisawa Kiyoshi; Gonzalez Adriana; Segi Eric; Johnson David H; Narumiya Shuh; Carbone David P
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
Cancer research 2006;66(19):9665-72.
2006: Amann Joseph M; Chaurand Pierre; Gonzalez Adriana; Mobley James A; Massion Pierre P; Carbone David P; Caprioli Richard M
Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5142-50.
2006: Acuff Heath B; Sinnamon Mark; Fingleton Barbara; Boone Braden; Levy Shawn E; Chen Xiwu; Pozzi Ambra; Carbone David P; Schwartz Donald R; Moin Kamiar; Sloane Bonnie F; Matrisian Lynn M
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.
Cancer research 2006;66(16):7968-75.
2006: Rosenthal David I; Fuller Clifton David; Machtay Mitchell; Algazy Kenneth M; Meyer Dan M; Kaiser Larry R; Yardley Denise A; Loiacano Megan E; Carbone David P
Phase I study of Paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(1):38-45.
2006: Lee Choon-Taek; Lee Yoon-Jin; Kwon Sung-Youn; Lee Jaeho; Kim Kwang Il; Park Kyung-Ho; Kang Joo Hyun; Yoo Chul-Gyu; Kim Young Whan; Han Sung Koo; Chung June-Key; Shim Young-Soo; Curiel David T; Carbone David P
In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27.
Cancer research 2006;66(1):372-7.
2006: Csiki Ildiko; Yanagisawa Kiyoshi; Haruki Nobuhiro; Nadaf Sorena; Morrow Jason D; Johnson David H; Carbone David P
Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer.
Cancer research 2006;66(1):143-50.
2005: Rahman S M Jamshedur; Shyr Yu; Yildiz Pinar B; Gonzalez Adriana L; Li Huiming; Zhang Xueqiong; Chaurand Pierre; Yanagisawa Kiyoshi; Slovis Bonnie S; Miller Robert F; Ninan Mathew; Miller York E; Franklin Wilbur A; Caprioli Richard M; Carbone David P; Massion Pierre P
Proteomic patterns of preinvasive bronchial lesions.
American journal of respiratory and critical care medicine 2005;172(12):1556-62.
2005: Anumanthan G; Halder S K; Osada H; Takahashi T; Massion P P; Carbone D P; Datta P K
Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.
British journal of cancer 2005;93(10):1157-67.
2005: Csiki Ildiko; Morrow Jason D; Sandler Alan; Shyr Yu; Oates John; Williams Myles K; Dang Thao; Carbone David P; Johnson David H
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6634-40.
2005: Carbone David P; Ciernik I Frank; Kelley Michael J; Smith M Charles; Nadaf Sorena; Kavanaugh Denise; Maher V Ellen; Stipanov Michael; Contois David; Johnson Bruce E; Pendleton C David; Seifert Burkhardt; Carter Charley; Read Elizabeth J; Greenblatt Jay; Top Lois E; Kelsey Morris I; Minna John D; Berzofsky Jay A
Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5099-107.
2005: Haruki Nobuhiro; Kawaguchi Keiko S; Eichenberger Shannon; Massion Pierre P; Olson Sandra; Gonzalez Adriana; Carbone David P; Dang Thao P
Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers.
Cancer research 2005;65(9):3555-61.
2005: Min Y; Adachi Y; Yamamoto H; Imsumran A; Arimura Y; Endo T; Hinoda Y; Lee C-T; Nadaf S; Carbone D P; Imai K
Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts.
Gut 2005;54(5):591-600.
2005: Herbst Roy S; Johnson David H; Mininberg Eric; Carbone David P; Henderson Ted; Kim Edward S; Blumenschein George; Lee Jack J; Liu Diane D; Truong Mylene T; Hong Waun K; Tran Hai; Tsao Anne; Xie Dong; Ramies David A; Mass Robert; Seshagiri Somasekar; Eberhard David A; Kelley Sean K; Sandler Alan
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(11):2544-55.
2005: Shinohara Eric T; Gonzalez Adriana; Massion Pierre P; Chen Heidi; Li Ming; Freyer Andrea S; Olson Sandra J; Andersen Jeremiah J; Shyr Yu; Carbone David P; Johnson David H; Hallahan Dennis E; Lu Bo
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.
Cancer 2005;103(8):1685-92.
2005: Amann Joseph; Kalyankrishna Shailaja; Massion Pierre P; Ohm Joyce E; Girard Luc; Shigematsu Hisayuki; Peyton Michael; Juroske Denise; Huang Yuhui; Stuart Salmon J; Kim Young H; Pollack Jonathan R; Yanagisawa Kiyoshi; Gazdar Adi; Minna John D; Kurie Jonathan M; Carbone David P
Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.
Cancer research 2005;65(1):226-35.
2005: Dikov Mikhail M; Ohm Joyce E; Ray Neelanjan; Tchekneva Elena E; Burlison Jared; Moghanaki Drew; Nadaf Sorena; Carbone David P
Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(1):215-22.
2004: Yang Li; DeBusk Laura M; Fukuda Koari; Fingleton Barbara; Green-Jarvis Brenda; Shyr Yu; Matrisian Lynn M; Carbone David P; Lin P Charles
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.
Cancer cell 2004;6(4):409-21.
2004: Lee Choon-Taek; Park Kyung-Ho; Yanagisawa Kiyoshi; Adachi Yasushi; Ohm Joyce E; Nadaf Sorena; Dikov Mikhail M; Curiel David T; Carbone David P
Combination therapy with conditionally replicating adenovirus and replication defective adenovirus.
Cancer research 2004;64(18):6660-5.
2004: Lu B; Gonzalez A; Massion P P; Shyr Y; Shaktour B; Carbone D P; Hallahan D E
Nuclear survivin as a biomarker for non-small-cell lung cancer.
British journal of cancer 2004;91(3):537-40.
2004: Massion Pierre P; Taflan Peter M; Rahman S M Jamshedur; Yildiz Pinar; Shyr Yu; Carbone David P; Gonzalez Adriana L
Role of p63 amplification and overexpression in lung cancer development.
Chest 2004;125(5 Suppl):102S.
2004: Adachi Yasushi; Lee Choon-Taek; Carbone David P
Genetic blockade of the insulin-like growth factor 1 receptor for human malignancy.
Novartis Foundation symposium 2004;262():177-89; discussion 190-2, 265-8.
2004: Yang Li; Carbone David P
Tumor-host immune interactions and dendritic cell dysfunction.
Advances in cancer research 2004;92():13-27.
2003: Massion Pierre P; Taflan Peter M; Jamshedur Rahman S M; Yildiz Pinar; Shyr Yu; Edgerton Mary E; Westfall Matthew D; Roberts John R; Pietenpol Jennifer A; Carbone David P; Gonzalez Adriana L
Significance of p63 amplification and overexpression in lung cancer development and prognosis.
Cancer research 2003;63(21):7113-21.
2003: Yamagata Noboru; Shyr Yu; Yanagisawa Kiyoshi; Edgerton Mary; Dang Thao P; Gonzalez Adriana; Nadaf Sorena; Larsen Paul; Roberts John R; Nesbitt Jonathan C; Jensen Roy; Levy Shawn; Moore Jason H; Minna John D; Carbone David P
A training-testing approach to the molecular classification of resected non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(13):4695-704.
2003: Min Yongfen; Adachi Yasushi; Yamamoto Hiroyuki; Ito Hideto; Itoh Fumio; Lee Choon-Taek; Nadaf Sorena; Carbone David P; Imai Kohzoh
Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer.
Cancer research 2003;63(19):6432-41.
2003: Yanagisawa Kiyoshi; Xu Baogang J; Carbone David P; Caprioli Richard M
Molecular fingerprinting in human lung cancer.
Clinical lung cancer 2003;5(2):113-8.
2003: Herbst Roy S; Hammond Lisa A; Carbone David P; Tran Hai T; Holroyd Kenneth J; Desai Avinash; Williams Jon I; Bekele B Nebiyou; Hait Howard; Allgood Victoria; Solomon Stephen; Schiller Joan H
A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4108-15.
2003: Yanagisawa Kiyoshi; Shyr Yu; Xu Baogang J; Massion Pierre P; Larsen Paul H; White Bill C; Roberts John R; Edgerton Mary; Gonzalez Adriana; Nadaf Sorena; Moore Jason H; Caprioli Richard M; Carbone David P
Proteomic patterns of tumour subsets in non-small-cell lung cancer.
Lancet 2003;362(9382):433-9.
2003: Ohm Joyce E; Gabrilovich Dmitry I; Sempowski Gregory D; Kisseleva Ekaterina; Parman Kelly S; Nadaf Sorena; Carbone David P
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression.
Blood 2003;101(12):4878-86.
2003: Dang Thao P; Eichenberger Shannon; Gonzalez Adriana; Olson Sandra; Carbone David P
Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice.
Oncogene 2003;22(13):1988-97.
2003: Yang Li; Yamagata Noboru; Yadav Rajwardhan; Brandon Suzanne; Courtney Regina L; Morrow Jason D; Shyr Yu; Boothby Mark; Joyce Sebastian; Carbone David P; Breyer Richard M
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.
The Journal of clinical investigation 2003;111(5):727-35.
2003: Lee Choon-Taek; Park Kyung-Ho; Adachi Yasushi; Seol Ja Young; Yoo Chul-Gyu; Kim Young Whan; Han Sung Koo; Shim Young-Soo; Coffee Keith; Dikov Mikhail M; Carbone David P
Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.
Cancer gene therapy 2003;10(1):57-63.
2003: Massion Pierre P; Carbone David P
The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.
Respiratory research 2003;4():12.
2002: Adachi Yasushi; Lee Choon-Taek; Coffee Keith; Yamagata Noboru; Ohm Joyce E; Park Kyung-Ho; Dikov Mikhail M; Nadaf Sorena R; Arteaga Carlos L; Carbone David P
Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines.
Gastroenterology 2002;123(4):1191-204.
2002: Gabrilovich Dmitry I; Cheng Pingyan; Fan Yuhong; Yu Bin; Nikitina Ekaterina; Sirotkin Allen; Shurin Michael; Oyama Tsunehiro; Adachi Yasushi; Nadaf Sorena; Carbone David P; Skoultchi Arthur I
H1(0) histone and differentiation of dendritic cells. A molecular target for tumor-derived factors.
Journal of leukocyte biology 2002;72(2):285-96.
2002: Swisher Stephen G; Roth Jack A; Carbone David P
Genetic and immunologic therapies for lung cancer.
Seminars in oncology 2002;29(1 Suppl 4):95-101.
2002: Ohm Joyce E; Carbone David P
Immune dysfunction in cancer patients.
Oncology (Williston Park, N.Y.) 2002;16(1 Suppl 1):11-8.
2001: Dikov M M; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich D I; Carbone D P
Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
Cancer research 2001;61(5):2015-21.
2001: Rosenthal D I; Lee J H; Sinard R; Yardley D A; Machtay M; Rosen D M; Egorin M J; Weber R S; Weinstein G S; Chalian A A; Miller L K; Frenkel E P; Carbone D P
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(5):1363-73.
2001: Jagasia M H; Langer C J; Johnson D H; Yunus F; Rodgers J S; Schlabach L L; Cohen A G; Shyr Y; Carbone D P; Devore R F
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(1):68-73.
2001: Nikitina E Y; Clark J I; Van Beynen J; Chada S; Virmani A K; Carbone D P; Gabrilovich D I
Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(1):127-35.
2001: Almand B; Clark J I; Nikitina E; van Beynen J; English N R; Knight S C; Carbone D P; Gabrilovich D I
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(1):678-89.
2001: Ohm J E; Carbone D P
VEGF as a mediator of tumor-associated immunodeficiency.
Immunologic research 2001;23(2-3):263-72.
2001: Almand B; Carbone D P
Biological considerations in lung cancer.
Cancer treatment and research 2001;105():1-30.
2000: Rosenthal D I; Becerra C R; Toto R D; Carbone D P; Frenkel E P
Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin.
American journal of clinical oncology 2000;23(6):593-8.
2000: Terabe M; Matsui S; Noben-Trauth N; Chen H; Watson C; Donaldson D D; Carbone D P; Paul W E; Berzofsky J A
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway.
Nature immunology 2000;1(6):515-20.
2000: Dang T P; Gazdar A F; Virmani A K; Sepetavec T; Hande K R; Minna J D; Roberts J R; Carbone D P
Chromosome 19 translocation, overexpression of Notch3, and human lung cancer.
Journal of the National Cancer Institute 2000;92(16):1355-7.
2000: Almand B; Resser J R; Lindman B; Nadaf S; Clark J I; Kwon E D; Carbone D P; Gabrilovich D I
Clinical significance of defective dendritic cell differentiation in cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1755-66.
1999: Carbone D P
Molecular modalities in the treatment of lung cancer.
Oncology (Williston Park, N.Y.) 1999;13(10 Suppl 5):142-7.
1999: Gabrilovich D I; Ishida T; Nadaf S; Ohm J E; Carbone D P
Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2963-70.
1999: Ohm J E; Shurin M R; Esche C; Lotze M T; Carbone D P; Gabrilovich D I
Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(6):3260-8.
1999: Ishida T; Chada S; Stipanov M; Nadaf S; Ciernik F I; Gabrilovich D I; Carbone D P
Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses.
Clinical and experimental immunology 1999;117(2):244-51.
1999: Matsui S; Ahlers J D; Vortmeyer A O; Terabe M; Tsukui T; Carbone D P; Liotta L A; Berzofsky J A
A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(1):184-93.
1999: Amorino G P; Freeman M L; Carbone D P; Lebwohl D E; Choy H
Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition.
International journal of radiation oncology, biology, physics 1999;44(2):399-405.
1999: Rosenthal D I; Nurenberg P; Becerra C R; Frenkel E P; Carbone D P; Lum B L; Miller R; Engel J; Young S; Miles D; Renschler M F
A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):739-45.
1999: Dowell J E; Sinard R; Yardley D A; Aviles V; Machtay M; Weber R S; Weinstein G S; Chalian A A; Carbone D P; Rosenthal D I
Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers.
Seminars in radiation oncology 1999;9(2 Suppl 1):97-101.
1998: Gabrilovich D; Ishida T; Oyama T; Ran S; Kravtsov V; Nadaf S; Carbone D P
Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.
Blood 1998;92(11):4150-66.
1998: Ishida T; Oyama T; Carbone D P; Gabrilovich D I
Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(9):4842-51.
1998: Lee J H; Lee C T; Yoo C G; Hong Y K; Kim C M; Han S K; Shim Y S; Carbone D P; Kim Y W
The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line.
Anticancer research 1998;18(5A):3257-61.
1998: Resser J R; Carbone D P
Immunotherapy of head and neck cancer.
Current opinion in oncology 1998;10(3):226-32.
1998: Oyama T; Ran S; Ishida T; Nadaf S; Kerr L; Carbone D P; Gabrilovich D I
Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(3):1224-32.
1997: Rosenthal D I; Sinard R J; Okani O; Corak J; Kavanaugh D; Kamen B; Vuitch F M; Gazdar A F; Griener J; Frenkel E P; Carbone D P
Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study.
Seminars in oncology 1997;24(6 Suppl 19):S19-67-S19-71.
1997: Rosenthal D I; Okani O; Corak J; Kavanaugh D; Kamen B; Vuitch F M; Gazdar A F; Greiner J; Frenkel E F; Carbone D P
Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I study.
Seminars in oncology 1997;24(4 Suppl 12):S12-96-S12-100.
1997: Carbone D P
The biology of lung cancer.
Seminars in oncology 1997;24(4):388-401.
1997: Smith M C; Pendleton C D; Maher V E; Kelley M J; Carbone D P; Berzofsky J A
Oncogenic mutations in ras create HLA-A2.1 binding peptides but affect their extracellular antigen processing.
International immunology 1997;9(8):1085-93.
1997: Gabrilovich D I; Corak J; Ciernik I F; Kavanaugh D; Carbone D P
Decreased antigen presentation by dendritic cells in patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(3):483-90.
1997: Rosenthal D I; Okani O; Truelson J M; Fathallah-Shaykh H; Vuitch F M; Gazdar A F; Griener J; Landay M; Mendelsohn D; Tourville J; Hamilton L; Orr K Y; McWhorter J; Carbone D P
Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies.
Seminars in oncology 1997;24(1 Suppl 2):S2-81-S2-84.
1996: Gabrilovich D I; Cunningham H T; Carbone D P
IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(6):414-8.
1996: Gabrilovich D I; Chen H L; Girgis K R; Cunningham H T; Meny G M; Nadaf S; Kavanaugh D; Carbone D P
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.
Nature medicine 1996;2(10):1096-103.
1996: Chen H L; Gabrilovich D; Virmani A; Ratnani I; Girgis K R; Nadaf-Rahrov S; Fernandez-Viña M; Carbone D P
Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer.
International journal of cancer. Journal international du cancer 1996;67(6):756-63.
1996: Tsukui T; Hildesheim A; Schiffman M H; Lucci J; Contois D; Lawler P; Rush B B; Lorincz A T; Corrigan A; Burk R D; Qu W; Marshall M A; Mann D; Carrington M; Clerici M; Shearer G M; Carbone D P; Scott D R; Houghten R A; Berzofsky J A
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.
Cancer research 1996;56(17):3967-74.
1996: Kavanaugh D Y; Carbone D P
Immunologic dysfunction in cancer.
Hematology/oncology clinics of North America 1996;10(4):927-51.
1996: Lee C T; Ciernik I F; Wu S; Tang D C; Chen H L; Truelson J M; Carbone D P
Increased immunogenicity of tumors bearing mutant p53 and P1A epitopes after transduction of B7-1 via recombinant adenovirus.
Cancer gene therapy 1996;3(4):238-44.
1996: Lee C T; Wu S; Gabrilovich D; Chen H; Nadaf-Rahrov S; Ciernik I F; Carbone D P
Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.
Cancer research 1996;56(13):3038-41.
1996: Ciernik I F; Berzofsky J A; Carbone D P
Human lung cancer cells endogenously expressing mutant p53 process and present the mutant epitope and are lysed by mutant-specific cytotoxic T lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):877-82.
1996: Ciernik I F; Krayenbühl B H; Carbone D P
Puncture-mediated gene transfer to the skin.
Human gene therapy 1996;7(8):893-9.
1996: Gabrilovich D I; Nadaf S; Corak J; Berzofsky J A; Carbone D P
Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
Cellular immunology 1996;170(1):111-9.
1996: Gabrilovich D I; Ciernik I F; Carbone D P
Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.
Cellular immunology 1996;170(1):101-10.
1996: Ciernik I F; Berzofsky J A; Carbone D P
Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(7):2369-75.
1996: Tang D C; Gazdar A F; Carbone D P
In vivo cytotoxicity assay for assessing immunity.
Journal of immunological methods 1996;189(2):173-82.
1995: Santoso J T; Tang D C; Lane S B; Hung J; Reed D J; Muller C Y; Carbone D P; Lucci J A; Miller D S; Mathis J M
Adenovirus-based p53 gene therapy in ovarian cancer.
Gynecologic oncology 1995;59(2):171-8.
1995: Ciernik I F; Krayenbühl Ciernik B H; Cockerell C J; Minna J D; Gazdar A F; Carbone D P
Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(10):1119-24.
1995: Ciernik I F; Berzofsky J; Carbone D P
Mutant oncopeptide immunization induces CTL specifically lysing tumor cells endogenously expressing the corresponding intact mutant p53.
Hybridoma 1995;14(2):139-42.
1995: Rosenthal D I; Carbone D P
Taxol plus radiation for head and neck cancer.
The Journal of infusional chemotherapy 1995;5(2):46-54.
1994: Sekido Y; Bader S A; Carbone D P; Johnson B E; Minna J D
Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines.
Cancer research 1994;54(18):4988-92.
1994: Wiedenfeld E A; Fernandez-Viña M; Berzofsky J A; Carbone D P
Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the HLA A*0201 peptide consensus motif.
Cancer research 1994;54(5):1175-7.
1994: Tang D C; Johnston S A; Carbone D P
Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors.
Cancer gene therapy 1994;1(1):15-20.
1994: Gazdar A F; Bader S; Hung J; Kishimoto Y; Sekido Y; Sugio K; Virmani A; Fleming J; Carbone D P; Minna J D
Molecular genetic changes found in human lung cancer and its precursor lesions.
Cold Spring Harbor symposia on quantitative biology 1994;59():565-72.
1993: Winter S F; Sekido Y; Minna J D; McIntire D; Johnson B E; Gazdar A F; Carbone D P
Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival.
Journal of the National Cancer Institute 1993;85(24):2012-8.
1993: Tang D C; Carbone D P
Potential application of gene therapy to lung cancer.
Seminars in oncology 1993;20(4):368-73.
1993: Yanuck M; Carbone D P; Pendleton C D; Tsukui T; Winter S F; Minna J D; Berzofsky J A
A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells.
Cancer research 1993;53(14):3257-61.
1993: Carbone D P
Oncogenes and tumor suppressor genes.
Hospital practice (Office ed.) 1993;28(6):145-8, 153-6, 161.
1992: Winter S F; Minna J D; Johnson B E; Takahashi T; Gazdar A F; Carbone D P
Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
Cancer research 1992;52(15):4168-74.
1992: D'Amico D; Carbone D P; Johnson B E; Meltzer S J; Minna J D
Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer.
Cancer research 1992;52(7):1996-9.
1992: Carbone D P; Minna J D
The molecular genetics of lung cancer.
Advances in internal medicine 1992;37():153-71.
1991: Carbone D P; Koros A M; Linnoila R I; Jewett P; Gazdar A F
Neural cell adhesion molecule expression and messenger RNA splicing patterns in lung cancer cell lines are correlated with neuroendocrine phenotype and growth morphology.
Cancer research 1991;51(22):6142-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

David Carbone

Research Profile (preview)

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of David Carbone (preview)

All Publications